Shanghai Fosun Pharmaceut... (SFOSF)
1.95
-0.06 (-2.99%)
At close: Apr 24, 2025, 8:00 PM
-2.99% (1D)
| Bid | 1.61 |
| Market Cap | 8.31B |
| Revenue (ttm) | 40.9B |
| Net Income (ttm) | 2.77B |
| EPS (ttm) | 0.14 |
| PE Ratio (ttm) | 13.89 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.99 |
| Volume | 200 |
| Avg. Volume (20D) | 820 |
| Open | 2.01 |
| Previous Close | 2.01 |
| Day's Range | 1.95 - 2.01 |
| 52-Week Range | 1.50 - 2.24 |
| Beta | 1.13 |
About SFOSF
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central n...
Sector Healthcare
IPO Date Apr 21, 2014
Employees 40,557
Stock Exchange PNK
Ticker Symbol SFOSF
Website https://www.fosunpharma.com